abstract |
Recombinant expression vectors are described which can be used for the expression of the malarial antigens HRPII or SERP or of parts thereof on the surface of gram-negative bacteria being capable of inducing a humoral immune response in mammals. Furthermore, corresponding Salmonella-based vaccines are described. |